Leslee Shaw

Director, Blavatnik Family Women’s Health Research Institute
Icahn School of Medicine at Mount Sinai

"We have to give all people a chance for a healthy life"

[Leslee Shaw @lesleejshaw]

horrible

[The New York Times @nytimes]

Breaking News: Homeland Security agents executed a search warrant at the home of Rep. Ilhan Omar of Minnesota. The Justice Department has historically avoided such investigative moves related to political candidates so close to elections. https://t.co/SZIbbIZmRH

[Leslee Shaw @lesleejshaw]

@landpalestine he's gone

[Emily Lau, MD, MPH @emilyswlau]

Applications for our 2027-2028 @MGBWomenHeart Fellowship are open! Deadline Oct 1, 2026.

Check out our @MGBWomenHeart Fellowship Alumni Spotlight with Anna O'Kelly!

[Stacey Abrams @staceyabrams]

Gloria Steinem understood power: of women, words and coalitions, and she used that power to transform a stubborn nation.

She built alliances without concern for how cynics might perceive them - and she lifted leaders long before others understood their promise.

Meeting heroes always risks disappointment, but knowing Gloria was an honor, where her humor and kindness were matched by a relentless belief that we could be better.

May the Lord bless her family and all who loved her.

[Jonathan Weir-McCall @JWeirMcCall]

Photon-counting CT is changing what we can see in the heart and lungs — and we're looking for a fellow to help lead that.

We are recruiting a Clinical Research Fellow in at the Royal Brompton Hospital to work with our two photon counting CTs dedicated to cardiothoracic imaging.

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

Happy 96th Birthday to our Queen 👑 @NanetteWenger

For paving the way
For opening the doors
For ensuring we are heard and for amplifying our voices
For teaching me to always take the high road but also for showing me when to get into the trenches
For teaching me when to say yes, and when to say no
For standing up for what is right
For being a mentor, sponsor, teacher and friend
We are blessed by having you in our lives
Have the Happiest Birthday. Love you!

[Stacey Rosen, M.D. @drstaceyrosen]

Congratulations @LPhillipsMD ! A well deserved promotion !! ❤️❤️

[Leslee Shaw @lesleejshaw]

I was the discussant for this trial at ESC. my take - too few higher risk, not intensive enough treatment goals, need more comprehensive bp and lifestyle recs. But, a huge start in the discussion to improve the initial risk assessment for primary prevention.

[Khurram Nasir @khurramn1]

thanks for sharing @DrMarthaGulati

My take on seeing the results shared on social media

1. CorCal, randomized trial of CAC vs PCE-guided statin allocation, found 72 vs 73 MACE events.... 2.7% in both arms (HR 0.99, 95% CI 0.72–1.38). No detected difference

2. Likely designed for much higher sample size and events, significantly less events then expected, probably stopped earlier..... unrealistic non inferiority bar, just hard to reach any conclusion (same, inferior, non inferior) but to be honest one can say no difference

3. I wonder if you think, should CAC be really considered a screening test? one should expect much higher use of statin if used for screening, actually shows CAC test to be a “subtractor” rather than adding treatment

4. This reframes the pragmatic question....whether a strategy that treats fewer appropriately selected patients causes harm?

5. CorCal appeared to show no MACE penalty with the more selective CAC strategy. This is reassuring, although not definitive proof of safety or equivalence (for now)

6. Adherence always our achilles heel. With CAC, individuals were considerably more likely to take statins (probably also higher dose), and achieved better LDL control

7. In essence, CAC allowed fewer patients to be directed toward therapy while strengthening treatment commitment among those selected.

8. This aligns with its current guideline role as a selective shared decision-making tool, and how used in clinical practice for the most…..not universal screening or a stand-alone treatment mandate

9. The key pending analysis is cost-effectiveness, including imaging, downstream testing, medication burden, events, and QALYs (societal value proposition)

@MichaelJBlaha @rblument1 @RonBlankstein @VietHeartPA @DrMichaelShapir @CiccaroneCenter @HMethodistCV @Sadeer_AlKindi @BudoffMd @lesleejshaw

[JACC Journals @JACCJournals]

Automated #DeepLearning–quantified TPV improved prediction of first coronary events beyond SCORE2, CAC, and coronary CTA measures, identifying elevated risk even with small plaque volumes in people without established #ASCVD. https://t.co/9WZGM8zfxx

#ESCCongress #JACCIMG

[C Bucciarelli-Ducci @chiarabd]

A very proud moment: my new proposed definition of MINOCA with the “I” for “injury” and not “infarction”, has been adopted worldwide by the 5th Definition of Myocardial Infarction Guideline by @escardio, @ACCinTouch, @AHAScience @worldheartfed

An important step in making an accurate diagnosis for adequate treatment.

new definition of MINOCA https://t.co/NHzMNhcxAR

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Coronary CT angiography for risk stratification among young adults: Prevalence of atherosclerosis and long-term outcomes

🔗 https://t.co/GjyaG6Lnro

@ArthurShiyovich @RonBlankstein @ghoshhajra

#YesCCT #CVprevention #Cardiology #CardioTwitter #CardioX

[Keith C. Ferdinand, MD, FACC, FAHA, FNLA @kcferdmd]

Honored to be recognized by the New Orleans City Council. Heart health equity and community care have been my life's work, and this belongs to all of us fighting for healthier futures in NOLA. https://t.co/epXdNv9cdr

[Caristo Diagnostics @CaristoHeart]

Caristo’s CaRi-Heart® debuts in the U.S.! A landmark moment for #cardiovascularcare — and a major win for science, clinicians, and patients! 🎉CaRi-Heart has received U.S. FDA De Novo authorization, becoming the first and only technology authorized in the U.S. to detect and quantify coronary inflammation from routine coronary CT angiography (CCTA).

This milestone reflects more than a decade of pioneering science, relentless work, and shared belief in a future where cardiovascular disease can be detected earlier, treated more personally, and patients can live longer, healthier lives.

Read the full announcement: https://t.co/bhwzypkL6D #CaRiHeart #CaristoDiagnostics #CoronaryInflammation #FAIScore #PreventiveCardiology #CardiacCT #AIinHealthcare #MedTech #FDA #Cardiology

[Leslee Shaw @lesleejshaw]

awesome choices

[Heart_SCCT @Heart_SCCT]

We're pleased to introduce the #yesCCT 2026 - 2027 leadership team, its Executive Committee and Board members, led by its 21st President Ronen Rubinshtein, MD, MSCCT.

Read more https://t.co/ZiJbIqbR2C

[C. Michael Gibson MD @CMichaelGibson]

Congratulations to my friend and colleague Justine Varieur Turco @Justine_Turco who has been named CEO/Executive Director of The Society of Thoracic Surgeons !
https://t.co/jZxC3iDEje

[Cardiovascular Business @CardioBusiness]

Cardiac imaging expert Ron Blankstein, MD, Brigham and Women's Hospital, provides an overview of how CCTA may soon become a paradigm shift in cardiac prevention.

#YesCCT #SCCT2026 #Cardiology #preventivecardiology #radiology https://t.co/Ii3FF2o9uU

[Mount Sinai Fuster Heart Hospital @MountSinaiHeart]

Congratulations to Dr. Deepak L. Bhatt on his appointment as the Dean for Clinical Research–Industry Partnerships at @IcahnMountSinai. As Dean, @DLBHATTMD will spearhead efforts to build an integrated Health System-wide clinical trial portfolio that advances scientific discovery.

[Cardiovascular Business @CardioBusiness]

New SCCT president, a veteran cardiologist, highlights importance of listening and teamwork @Heart_SCCT #cardiology #imaging #radiology https://t.co/I6jGFDZvmN

[Khurram Nasir @khurramn1]

Where do u draw the line?

Majority in our SCCT debate agreed “Power of Zero” is good enough… as also has the “Power of Value”

Great reporting @TCTMD_Yael 👏👏

[Solomon W. Bienstock, MD @SWBienMD]

Welcome to our new cardiac imaging fellows @MountSinaiHeart @MSHCVImaging! @HarryChoi @DLBHATTMD @lesleejshaw @SinaiCards